Purchases and Sales Made in Q2 2022 in Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO) during Q2 2022. The information is specifically focused on institutions that hold shares of AGIOS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-142K- 7.84% |
$2.43M - $4.47M
|
1.67M
$99.5M
|
|
|
Aug 15, 2022
Q2 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-155K- 5.72% |
$2.64M - $4.86M
|
2.55M
$151M
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-364K- 7.0% |
$6.21M - $11.4M
|
4.84M
$287M
|
|
|
Aug 15, 2022
Q2 2022
|
Casdin Capital, LLC
New York, NY |
SELL
|
- |
-1.31M- 62.44% |
$22.3M - $41M
|
785K
$46.6M
|
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.87M- 56.96% |
$31.8M - $58.6M
|
1.41M
$83.7M
|